Clinical Trials on KRAS G12C Mutant Advanced Solid Tumors
Total 1972 results
-
Five Prime Therapeutics, Inc.CompletedAdvanced Solid TumorsKorea, Republic of, Australia
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedAdvanced Solid TumorsUnited States, Japan
-
Wigen Biomedicine Technology (Shanghai) Co., Ltd.Sponsor GmbHEnrolling by invitation
-
AbbVieCompleted
-
TransThera Sciences (Nanjing), Inc.CompletedAdvanced Solid TumorsTaiwan
-
Eucure (Beijing) Biopharma Co., LtdCompleted
-
Suzhou Junjing BioSciences Co., Ltd.Terminated
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
Qilu Pharmaceutical Co., Ltd.Active, not recruitingAdvanced Solid TumorsChina
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Calithera Biosciences, IncCompletedAdvanced Solid TumorsUnited States
-
InnoCare Pharma Inc.Active, not recruitingAdvanced Solid TumorsUnited States
-
Eucure (Beijing) Biopharma Co., LtdCompleted
-
Eucure (Beijing) Biopharma Co., LtdCompletedAdvanced Solid TumorsAustralia
-
Y Biologics Inc.Novotech (Australia) Pty LimitedActive, not recruitingAdvanced Solid TumorsKorea, Republic of, Thailand, Australia
-
Shanghai De Novo Pharmatech Co., Ltd.CompletedAdvanced Solid TumorsUnited States
-
Shanghai Antengene Corporation LimitedTerminatedAdvanced Solid TumorsChina
-
Onconic Therapeutics Inc.Jeil Pharmaceutical Co., Ltd.CompletedAdvanced Solid TumorsKorea, Republic of
-
Constellation PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
TyrogenexCompleted
-
CStone PharmaceuticalsCompleted
-
ImmunityBio, Inc.Completed
-
Cyclacel Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
BeiGeneTerminatedAdvanced Solid TumorsAustralia, Spain, New Zealand
-
TakedaCompletedAdvanced Solid TumorsJapan
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Shanghai Miracogen Inc.Completed
-
MedImmune LLCCompletedStudy to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Japan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsSwitzerland, Netherlands, United States, United Kingdom
-
Sunshine Lake Pharma Co., Ltd.CompletedAdvanced Solid TumorsChina
-
BioMed Valley Discoveries, IncCompletedAdvanced Solid TumorsUnited States
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Solid TumorsChina
-
MedImmune LLCCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced Solid TumorsUnited States
-
Hoffmann-La RocheCompletedAdvanced Solid TumorsUnited States, France
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.Unknown
-
AbbVieCompleted
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Solid Tumors
-
Taiho Pharmaceutical Co., Ltd.CompletedAdvanced Solid TumorsJapan
-
Sunesis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Georgetown UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
GenSpera, Inc.CompletedAdvanced Solid TumorsUnited States
-
PfizerCompletedA First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Korea, Republic of, Italy
-
PfizerWithdrawnAdvanced Solid Tumors
-
AmgenTerminatedAdvanced Solid TumorsUnited States
-
Human Genome Sciences Inc.CompletedAdvanced Solid TumorsUnited States
-
BiogenCompletedAdvanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompletedAdvanced Solid TumorsUnited States
-
Jubilant Innovation Ltd.CompletedAdvanced Solid TumorsUnited States